Prudential Financial
IMGN

Prudential Financial’s Immunogen Inc IMGN Stock Holding History

Prudential Financial’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,221
Closed -$540K – 2790
2023
Q4 		$540K Sell
18,221
-60,427
-77% -$1.2M ﹤0.01% 2108
2023
Q3 		$1.25M Sell
78,648
-192,246
-71% -$3.2M ﹤0.01% 1649
2023
Q2 		$5.11M Sell
270,894
-414,881
-60% -$4.9M 0.01% 887
2023
Q1 		$2.63M Sell
685,775
-446,303
-39% -$1.9M ﹤0.01% 1161
2022
Q4 		$5.62M Sell
1,132,078
-29,316
-3% -$159K 0.01% 824
2022
Q3 		$5.55M Buy
1,161,394
+991,712
+584% +$5.23M 0.01% 856
2022
Q2 		$764K Buy
169,682
+152,368
+880% +$662K ﹤0.01% 1925
2022
Q1 		$83K Buy
17,314
+432
+3% +$2.39K ﹤0.01% 2555
2021
Q4 		$115K Sell
16,882
-484
-3% -$3.01K ﹤0.01% 2575
2021
Q3 		$101K Buy
17,366
+947
+6% +$5.47K ﹤0.01% 2532
2021
Q2 		$108K Buy
16,419
+413
+3% +$2.88K ﹤0.01% 2497
2021
Q1 		$130K Buy
16,006
+579
+4% +$4.73K ﹤0.01% 2436
2020
Q4 		$100K Buy
15,427
+1,411
+10% +$8.23K ﹤0.01% 2394
2020
Q3 		$51K Sell
14,016
-229
-2% -$925 ﹤0.01% 2387
2020
Q2 		$65K Buy
14,245
+1,350
+10% +$5.74K ﹤0.01% 2353
2020
Q1 		$44K Buy
12,895
+218
+2% +$953 ﹤0.01% 2309
2019
Q4 		$65K Buy
12,677
+580
+5% +$1.97K ﹤0.01% 2390
2019
Q3 		$29K Sell
12,097
-2,311
-16% -$6.14K ﹤0.01% 2392
2019
Q2 		$31K Buy
14,408
+1,436
+11% +$3.4K ﹤0.01% 2439
2019
Q1 		$35K Sell
12,972
-220
-2% -$953 ﹤0.01% 2413
2018
Q4 		$63K Sell
13,192
-690
-5% -$4.19K ﹤0.01% 2329
2018
Q3 		$131K Sell
13,882
-8,920
-39% -$85.7K ﹤0.01% 2366
2018
Q2 		$222K Buy
+22,802
New +$240K ﹤0.01% 2315
2017
Q1 		– Sell
-16,442
Closed -$34K – 2378
2016
Q4 		$34K Sell
16,442
-8,200
-33% -$16.5K ﹤0.01% 2319
2016
Q3 		$66K Sell
24,642
-6,390
-21% -$18.6K ﹤0.01% 2293
2016
Q2 		$96K Sell
31,032
-139,800
-82% -$877K ﹤0.01% 2254
2016
Q1 		$1.46M Sell
170,832
-328,800
-66% -$2.78M ﹤0.01% 1683
2015
Q4 		$6.78M Buy
499,632
+74,000
+17% +$911K 0.01% 953
2015
Q3 		$4.09M Buy
425,632
+37,700
+10% +$551K 0.01% 1128
2015
Q2 		$5.58M Buy
387,932
+240,000
+162% +$2.64M 0.01% 1044
2015
Q1 		$1.32M Buy
147,932
+93,800
+173% +$679K ﹤0.01% 1744
2014
Q4 		$330K Buy
54,132
+43,900
+429% +$401K ﹤0.01% 2021
2014
Q3 		$108K Sell
10,232
-163,456
-94% -$1.85M ﹤0.01% 2166
2014
Q2 		$2.06M Sell
173,688
-38,844
-18% -$488K ﹤0.01% 1498
2014
Q1 		$3.17M Buy
212,532
+94,400
+80% +$1.49M 0.01% 1212
2013
Q4 		$1.73M Sell
118,132
-2,900
-2% -$44.6K ﹤0.01% 1524
2013
Q3 		$2.06M Buy
121,032
+47,900
+65% +$842K ﹤0.01% 1406
2013
Q2 		$1.21M Buy
+73,132
New +$1.19M ﹤0.01% 1631

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prudential Financial's IMGN Position: Q1 2024 in Review

Prudential Financial sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 18,221 shares — an estimated $540K sold.

Prudential Financial first reported a position in IMGN in Q2 2013 and held it in 38 quarters. The position peaked at $6.78M in Q4 2015. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Prudential Financial reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Prudential Financial sold 18,221 Immunogen Inc shares in Q1 2024, an estimated $540K.
  • Prudential Financial first reported a position in Immunogen Inc in Q2 2013 and held it in 38 quarters.
  • Prudential Financial's Immunogen Inc position peaked at $6.78M in Q4 2015.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Prudential Financial's 13F filing for Q1 2024, filed 14 May 2024.